Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.

The objective of this clinical study is to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of SV003 in healthy subjects.

Participants needed: 60
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Shanghai Synvida Biotechnology Co.,Ltd.Updated: Apr 8, 2026Locations: 1
Eligibility criteria

Body Mass Index (BMI): 18.5 ≤ Chinese participants ≤ 30 kg/m², 18.5 ≤ Caucasian... [+2]

Subjects with a history of chronic diseases or currently presenting with clinica... [+14]

Read more
Status: Recruiting

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

The purpose of this study is to evaluate safety, tolerability, PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers.

Participants needed: 53
Trial details
Phase: Early Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Shanghai Synvida Biotechnology Co.,Ltd.Updated: Mar 11, 2026Locations: 1
Eligibility criteria

Subjects must fully understand the purpose, characteristics, methods and possibl... [+3]

Subjects with a history of drug or other substance anaphylaxis; [+15]

Read more
Status: Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

The purpose of this study is to evaluate the safety, tolerability, PK and immunogenicity of SV001 in patients with idiopathic pulmonary fibrosis.

Participants needed: 48
Trial details
Phase: Phase 2Age: 40+Biological sex: AllType: InterventionalSponsor: Shanghai Synvida Biotechnology Co.,Ltd.Updated: Feb 11, 2026Locations: 12
Eligibility criteria

Subjects with a confirmed diagnosis of IPF and pulmonary function meeting the pr... [+2]

Subjects with a history of drug or other allergies, or those judged by the inves... [+15]

Read more